Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark John Austin currently holds 34,500 shares of Perspective Therapeutics, Inc. (CATX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark John Austin has been a net buyer of CATX stock. They have purchased $22.7K and sold $0 worth of shares.
Mark John Austin's most recent insider trade was on Jul 17, 2024, when they sold 34,500 shares at $0.00 per share.
Mark John Austin serves as Executive at Perspective Therapeutics, Inc. (CATX). They have executed 14 insider transactions totaling $22.7K over their tenure at the company.
Mark John Austin holds the position of Executive at Perspective Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Mark John Austin has shown a buying trading pattern, with $22.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Mark John Austin was on Apr 23, 2024, when they sold $10.8K worth of CATX shares. This transaction involved 30,000 shares at $0.36 per share.
Mark John Austin currently owns 34,500 shares of Perspective Therapeutics, Inc. (CATX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark John Austin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark John Austin has 14 Form 4 filings on record as an insider at Perspective Therapeutics, Inc..
Set alerts for Mark John Austin and 40,000+ other insiders.